NRIX Competitors & Alternatives
Compare Nurix Therapeutics Inc with similar stocks in the same industry
Biotechnology
NRIX
Main Stock$16.06
Tradestie Score
46
Market Cap
$718.62M
P/E Ratio
6.6
Revenue Growth
84.3%
Analyst Upside
+108.7%
Top Competitors
218 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
LQDA
Liquidia Corporation Common Stock
|
$51.40
|
$1.90B | 34.4 | 28 | Compare |
|
VERA
Vera Therapeutics, Inc. Class A Common Stock
|
$30.03
|
$1.84B | - | 47 | Compare |
|
IMCR
Immunocore Holdings plc American Depositary Shares
|
$32.38
|
$1.81B | - | 53 | Compare |
|
ABCL
AbCellera Biologics Inc. Common Shares
|
$12.76
|
$1.78B | - | 60 | Compare |
|
DYN
Dyne Therapeutics, Inc. Common Stock
|
$17.92
|
$1.78B | - | 36 | Compare |
|
TWST
Twist Bioscience Corporation Common Stock
|
$132.13
|
$1.77B | - | 57 | Compare |
|
VRDN
Viridian Therapeutics, Inc. Common Stock
|
$30.86
|
$1.74B | - | 39 | Compare |
|
CLDX
Celldex Therapeutics, Inc
|
$30.65
|
$1.68B | - | 63 | Compare |
|
MNKD
Mannkind Corporation
|
$4.23
|
$1.65B | - | 47 | Compare |
|
EWTX
Edgewise Therapeutics, Inc. Common Stock
|
$46.53
|
$1.63B | 5.8 | 48 | Compare |
More NRIX Analysis
Data updated: Nov 11, 2026 | Industry: Biotechnology (SIC 2834)
218 stocks in this industry